Umeclidinium
RxNorm 1487514
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1487514 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: umeclidinium.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing umeclidinium (medicinal product)
(Atom ID: 10319490)
INPrescribable
Ingredient (IN):
Umeclidinium
(Atom ID: 5940805)
PTPrescribable
Designated preferred name (PT):
Umeclidinium
(Atom ID: 6829699)
FNPrescribable
Full form of descriptor (FN):
Umeclidinium (substance)
(Atom ID: 6829700)
PTPrescribable
Designated preferred name (PT):
Umeclidinium-containing product
(Atom ID: 10822415)
Patient Education
Umeclidinium Oral Inhalation
Umeclidinium oral inhalation is used in adults to control wheezing, shortness of breath, coughing, and chest tightness caused by chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways, that includes chronic bronchitis and emphysema). Umeclidinium inhalation is in a class of medications called anticholinergics. It works by relaxing and opening air passages in the lungs, making it easier to breathe.
[Learn More]
* Please review the disclaimer below.